NCT03492606View on ClinicalTrials.gov

Lipid Mediators in Multiple Sclerosis

CompletedOBSERVATIONAL
Enrollment

150

Participants

Timeline

Start Date

March 1, 2019

Primary Completion Date

September 9, 2020

Study Completion Date

January 9, 2021

Conditions
Multiple Sclerosis
Interventions
PROCEDURE

Samples

lumbar puncture, blood and CSF samples, SNPs analysis

Trial Locations (1)

86077

IRCCS Neuromed, Pozzilli

All Listed Sponsors
lead

Neuromed IRCCS

OTHER

NCT03492606 - Lipid Mediators in Multiple Sclerosis | Biotech Hunter | Biotech Hunter